EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
批准号:
6476260
负责人:
Erik Mills Schwiebert
金额:
$16.44万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-01-15 至 2004-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cystic fibrosis (CF) is a disease of exocrine epithelia. Not only is a lack of cyclic AMP-activated chloride (C1-) channel activity observed in CF epithelial cells, but dysregulation of other epithelial C1- and Na+ channels, epithelial vesicle trafficking, and epithelial immune function are also observed in CF. The PI has shown recently that there is a loss of ATP release across the apical membrane of CF epithelia under basal or isotonic and hypotonic conditions and that extracellular ATP signaling may be lost in CF. Without basal or stimulated ATP release in CF epithelia, we hypothesize that the pathogenesis of CF epithelial dysfunction may lie in defective ATP signaling and defective cell volume regulation by the CF epithelia. An ionic imbalance in the airway surface liquid has been observed; we hypothesize that this reflects an osmotic imbalance due to an inherent defect in autocrine ATP control of epithelial cell volume regulation. As such, this completely re-constructed proposal focuses on one concise, central hypothesis: ATP release and signaling is essential for autocrine control of cell volume regulation. Two aims derive from this hypothesis: (1) Test the hypothesis that RVD requires ATP release, ATP receptors, and CFTR expression in the plasma membrane, and (2) Test the hypothesis that ATP release occurs via transport- and exocytotic-driven mechanisms. To fulfill these Aims, parental CF epithelial cells will be compared to CF cells complemented transiently or stably with wild-type CFTR. A synergistic combination of cell volume regulation assays, bioluminescence detection assays of ATP released from cells, patch-clamp electrophysiological assays of ATP whole cell current and membrane capacitance, and exocytosis assays will be used to address each Aim. These assays will identify the ATP release mechanisms, the dependence of these mechanisms upon CFTR expression, and the purinergic receptors involved in autocrine ATP control of cell volume regulation. We are confident that novel results will be found concerning the cellular and molecular mechanisms of autocrine ATP release, signaling, and regulation of cell volume.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia
-
批准号:9139596
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2016
-
负责人:Erik Mills Schwiebert
-
依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
-
批准号:8454042
-
项目类别:
-
资助金额:$43.66万
-
财政年份:2013
-
负责人:Erik Mills Schwiebert
-
依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
-
批准号:8803107
-
项目类别:
-
资助金额:$50.34万
-
财政年份:2013
-
负责人:Erik Mills Schwiebert
-
依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
-
批准号:8892174
-
项目类别:
-
资助金额:$63.17万
-
财政年份:2013
-
负责人:Erik Mills Schwiebert
-
依托单位:
Discovery of Inhibitors of PTH-Wnt Signaling Synergy in Bone Cells
-
批准号:8000306
-
项目类别:
-
资助金额:$23.43万
-
财政年份:2010
-
负责人:Erik Mills Schwiebert
-
依托单位:
Discovery of Novel Anti-Inflammatory Phytochemicals on Human Cell Platforms
-
批准号:7926261
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2010
-
负责人:Erik Mills Schwiebert
-
依托单位:
CF Corrector Ligands Discovered on CF Human Airway Cells
-
批准号:8200582
-
项目类别:
-
资助金额:$72.62万
-
财政年份:2009
-
负责人:Erik Mills Schwiebert
-
依托单位:
Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis
-
批准号:7853245
-
项目类别:
-
资助金额:$1.55万
-
财政年份:2009
-
负责人:Erik Mills Schwiebert
-
依托单位:
Cystic Fibrosis Corrector Ligands Discovered in CF Human Airway Cells
-
批准号:7748575
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2009
-
负责人:Erik Mills Schwiebert
-
依托单位:
CF Corrector Ligands Discovered on CF Human Airway Cells
-
批准号:8330822
-
项目类别:
-
资助金额:$65.14万
-
财政年份:2009
-
负责人:Erik Mills Schwiebert
-
依托单位:
Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis
-
批准号:7612426
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2008
-
负责人:Erik Mills Schwiebert
-
依托单位:
Ion Transport Dysregulation in Cilium-deficient ARPKD
-
批准号:6989180
-
项目类别:
-
资助金额:$27.59万
-
财政年份:2005
-
负责人:Erik Mills Schwiebert
-
依托单位:
Ion Transport Dysregulation in Cilium-deficient ARPKD
-
批准号:7108698
-
项目类别:
-
资助金额:$26.21万
-
财政年份:2005
-
负责人:Erik Mills Schwiebert
-
依托单位:
EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
-
批准号:6624922
-
项目类别:
-
资助金额:$16.94万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EPITHELIAL P2X PURINERGIC RECEPTOR CHANNELS
-
批准号:6033315
-
项目类别:
-
资助金额:$21.2万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EPITHELIAL P2X PURINERGIC RECEPTOR CHANNELS
-
批准号:6351601
-
项目类别:
-
资助金额:$18.98万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
-
批准号:6329424
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
-
批准号:6683657
-
项目类别:
-
资助金额:$17.44万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
-
批准号:6044885
-
项目类别:
-
资助金额:$18.77万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EPITHELIAL P2X PURINERGIC RECEPTOR CHANNELS
-
批准号:6499035
-
项目类别:
-
资助金额:$19.55万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
海外基金